Leukoaraiosis and early neurological recovery after intravenous thrombolysis

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 9, 2014, Pages 2431-2436

  McAlpine, Heidi ^a   Churilov, Leonid ^b,c   Mitchell, Peter ^a   Dowling, Richard ^a   Teo, Sarah ^a   Yan, Bernard ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Leukoaraiosis; recovery; stroke; thrombolysis; white matter hyperintensity of presumed vascular origin

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; ARTICLE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; IMAGE ANALYSIS; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; AGE; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; LEUKOARAIOSIS; MALE; RECOVERY OF FUNCTION; RISK FACTORS; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84908006012     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.05.012     Document Type: Article

References (30)

1. C.J. Murray, and A.D. Lopez Mortality by cause for eight regions of the world: Global Burden of Disease Study Lancet 349 1997 1269 1276
2. Tissue plasminogen activator for acute ischemic stroke New England Journal of Medicine 333 1995 1581 1588
3. W. Hacke, M. Kaste, and C. Fieschi Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) The Lancet 352 1998 1245 1251
4. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. The Lancet;369:275-282.
5. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet;379:2352-2363.
6. D.L. Brown, K.C. Johnston, and D.P. Wagner Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke Stroke 35 2004 147 150
7. B. Machumpurath, S.M. Davis, and B. Yan Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome Cerebrovascular diseases 31 2011 278 283
8. G. Saposnik, S. Di Legge, and F. Webster Predictors of major neurologic improvement after thrombolysis in acute stroke Neurology 65 2005 1169 1174
9. I.-P. Muresan, P. Favrole, and P. Levy Very early neurologic improvement after intravenous thrombolysis Archives of neurology 67 2010 1323 1328
10. D.B. Boddu, V.C.S. Srinivasarao Bandaru, and P.G. Reddy Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India Neurology India 58 2010 403 406
11. R.A. Felberg, N.J. Okon, and A. El-Mitwalli Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke Stroke 33 2002 1301 1307
12. T. Kharitonova, R. Mikulik, and R.O. Roine Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke Stroke 42 2011 1638 1643
13. P. Dharmasaroja, P. Dharmasaroja, and S. Muengtaweepongsa Early outcome after intravenous thrombolysis in patients with acute ischemic stroke Neurology India 59 2011 351 354
14. M.J.H. Aries, M. Uyttenboogaart, and P.C. Vroomen tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. European journal of neurology Eur J Neurol 17 2010 866 870
15. E.M. Arsava, A. Bayrlee, and M. Vangel Severity of leukoaraiosis determines clinical phenotype after brain infarction Neurology 77 2011 55 61
16. E. Auriel, L. Csiba, and E. Berenyi Leukoaraiosis is associated with arterial wall thickness: a quantitative analysis Neuropathology 32 2012 227 233
17. A. Podgorska, D.B. Hier, and A. Pytlewski Leukoaraiosis and stroke outcome J Stroke Cerebrovasc Dis 11 2002 336 340
18. S. Koton, Y. Schwammenthal, and O. Merzeliak Cerebral leukoaraiosis in patients with stroke or TIA: clinical correlates and 1-year outcome Eur J Neurol 16 2009 218 225
19. A.M. Demchuk, F. Khan, and M.D. Hill Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study Cerebrovasc Dis 26 2008 120 125
20. J.C. van Swieten, A. Hijdra, P.J. Koudstaal, and J. van Gijn Grading white matter lesions on CT and MRI: a simple scale J Neurol Neurosurg Psychiatry 53 1990 1080 1083
21. P. Scheltens, T. Erkinjunti, and D. Leys White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes European neurology 39 1998 80 89
22. V. Palumbo, J.M. Boulanger, and M.D. Hill Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke Neurology 68 2007 1020 1024
23. J.L. Saver, J. Gornbein, and S. Starkman Response to: "A graphic reanalysis of the NINDS Trial" Annals of emergency medicine 55 2010 226 227 author reply 9
24. L. Pantoni, J.H. Garcia, and J.A. Gutierrez Cerebral white matter is highly vulnerable to ischemia Stroke 27 1996 1641 1646 discussion 7
25. E. Auriel, N.M. Bornstein, and E. Berenyi Clinical, radiological and pathological correlates of leukoaraiosis Acta neurologica Scandinavica 123 2011 41 47
26. H.S. Markus, D.J. Lythgoe, and L. Ostegaard Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI Journal of neurology, neurosurgery, and psychiatry 69 2000 48 53
27. N. Tomura, K. Sasaki, and H. Kidani Reduced perfusion reserve in leukoaraiosis demonstrated using acetazolamide challenge 123I-IMP SPECT Journal of computer assisted tomography 31 2007 884 887
28. J.M. Wardlaw, E.E. Smith, and G.J. Biessels Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration Lancet neurology 12 2013 822 838
29. E.E. Smith Leukoaraiosis and stroke Stroke 41 2010 S139 S143
30. T. Neumann-Haefelin, S. Hoelig, and J. Berkefeld Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke Stroke 37 2006 2463 2466